Cite
TIR-TLR7 as a Molecular Adjuvant: Simultaneous Enhancing Humoral and Cell-Mediated Immune Responses Against Inactivated Infectious Bursal Disease Virus.
MLA
Ebrahimi, Mohammad Majid, et al. “TIR-TLR7 as a Molecular Adjuvant: Simultaneous Enhancing Humoral and Cell-Mediated Immune Responses Against Inactivated Infectious Bursal Disease Virus.” Viral Immunology, vol. 32, no. 6, July 2019, pp. 252–57. EBSCOhost, https://doi.org/10.1089/vim.2018.0158.
APA
Ebrahimi, M. M., Shahsavandi, S., & Shayan, P. (2019). TIR-TLR7 as a Molecular Adjuvant: Simultaneous Enhancing Humoral and Cell-Mediated Immune Responses Against Inactivated Infectious Bursal Disease Virus. Viral Immunology, 32(6), 252–257. https://doi.org/10.1089/vim.2018.0158
Chicago
Ebrahimi, Mohammad Majid, Shahla Shahsavandi, and Parviz Shayan. 2019. “TIR-TLR7 as a Molecular Adjuvant: Simultaneous Enhancing Humoral and Cell-Mediated Immune Responses Against Inactivated Infectious Bursal Disease Virus.” Viral Immunology 32 (6): 252–57. doi:10.1089/vim.2018.0158.